Synektik

Synektik Equity Ratio

The Equity Ratio of Synektik (SNT.WA) as of Oct 31, 2026 is 45.79 %. In the previous year, Equity Ratio was 50.64 % — a change of -9.58% (lower).

Equity Ratio

45.79 %

YoY

-9.58%

Last updated:

Equity Ratio of Synektik is 2025 45.79 % . Equity Ratio of Synektik was 2024 50.64 % . It decreases by -9.58% lower compared to the previous year.

The Synektik Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
57.08 PLN
Jan 1, 2019
56.16 PLN
Jan 1, 2020
53.66 PLN
Jan 1, 2021
50.45 PLN
Jan 1, 2022
37.15 PLN
Jan 1, 2023
44.75 PLN
Jan 1, 2024
50.64 PLN
Jan 1, 2025
45.79 PLN
The Synektik Equity Ratio history
YEAREquity RatioYoY
45.79 %-9.58%
50.64 %+13.17%
44.75 %+20.46%
37.15 %-26.37%
50.45 %-5.99%
53.66 %-4.44%
56.16 %-1.62%
57.08 %+6.58%
53.56 %-14.63%
62.74 %+15.84%
54.16 %-0.84%
54.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Equity Ratio of Synektik is 45.79 % in 2025.

Equity Ratio of Synektik changed from 50.64 % to 45.79 %, representing a -9.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Synektik since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Synektik with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Synektik

All Key Metrics — Synektik